MwanzoFBIOP • NASDAQ
add
Fortress Biotech 9 375 Cumulative Redeemable Perpetual Pref Shs Series A
Bei iliyotangulia
$ 5.10
Bei za siku
$ 5.03 - $ 5.22
Bei za mwaka
$ 4.86 - $ 18.00
Thamani ya kampuni katika soko
39.42M USD
Wastani wa hisa zilizouzwa
elfu 18.34
Uwiano wa bei na mapato
-
Mgao wa faida
-
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(USD) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 14.90M | -14.32% |
Matumizi ya uendeshaji wa biashara | 20.82M | -14.80% |
Mapato halisi | -10.95M | 55.81% |
Kiwango cha faida halisi | -73.50 | 48.42% |
Mapato kwa kila hisa | — | — |
EBITDA | -23.95M | 47.09% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(USD) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 76.20M | -2.33% |
Jumla ya mali | 145.68M | -19.39% |
Jumla ya dhima | 160.28M | -18.50% |
Jumla ya hisa | -14.60M | — |
hisa zilizosalia | 22.81M | — |
Uwiano wa bei na thamani | 6.46 | — |
Faida inayotokana na mali | -40.50% | — |
Faida inayotokana mtaji | -79.28% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(USD) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | -10.95M | 55.81% |
Pesa kutokana na shughuli | -21.84M | 34.40% |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | 14.26M | 146.95% |
Mabadiliko halisi ya pesa taslimu | -7.57M | 88.48% |
Mtiririko huru wa pesa | -12.56M | 63.48% |
Kuhusu
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida. Wikipedia
Ilianzishwa
2006
Makao Makuu
Tovuti
Wafanyakazi
186